Source: FinanzNachrichten

NeuMoDx: QIAGEN: NeuMoDx Multiplex Test Gets FDA Emergency Use Authorization To Differentiate COVID-19

VENLO (dpa-AFX) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test....

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jeffrey S. Williams's photo - Chairman & CEO of NeuMoDx

Chairman & CEO

Jeffrey S. Williams

CEO Approval Rating

89/100

Read more